SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (5288)2/5/1998 6:17:00 AM
From: blankmind  Read Replies (1) of 23519
 
- Vivus is behaving exactly how several of us predicted it would back in December.

- If you recall, when Vivus was in the $9-10 range, everyone said the sell-off was tax-related and bore no relation to the fundamentals of the company. Sure enough, the January effect has lifted the stock to the $15 level.

- And as previously predicted, I think the analysts are going to come back on board. Mutual funds will start accumulating. And the relatively cheap VVUS stock will go from $15 to $25 by quarter-end - 3/31/98. And the shorts are toast.

Out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext